Suchergebnisse - "Janetka, James W"

PubPharm (9)

1

Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis

enthalten in: Journal of medicinal chemistry | 2020

von Janetka, J. | Hopper, A. | Yang, Z. | +4

2

MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A

enthalten in: Science (New York, N.Y.) | 2018

von Rocha, A. | Franco, A. | Krezel, A. | +12

3

Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii

enthalten in: Journal of medicinal chemistry | 2017

von Rutaganira, F. | Barks, J. | Dhason, M. | +11

4

Death by releasing the breaks : CHK1 inhibitors as cancer therapeutics

enthalten in: Trends in molecular medicine | 2011

von Ma, C. | Janetka, J. | Piwnica-Worms, H.

5

Checkpoint kinase inhibitors : a review of the patent literature

enthalten in: Expert opinion on therapeutic patents | 2009

von Janetka, J. | Ashwell, S.

6

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

enthalten in: Molecular cancer therapeutics | 2008

von Zabludoff, S. | Deng, C. | Grondine, M. | +17

7

Keeping checkpoint kinases in line : new selective inhibitors in clinical trials

enthalten in: Expert opinion on investigational drugs | 2008

von Ashwell, S. | Janetka, J. | Zabludoff, S.

8

Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2008

von Janetka, J. | Almeida, L. | Ashwell, S. | +18

9

Inhibitors of checkpoint kinases : from discovery to the clinic

enthalten in: Current opinion in drug discovery & development | 2007

von Janetka, J. | Ashwell, S. | Zabludoff, S. | +1

1
[1]